Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.
Journal: British journal of haematology
Published: May 17, 2017
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2014
Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy.
Journal: Oncology
Published: February 21, 2014
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.
Journal: Annals of hematology
Published: February 11, 2013
A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026